FDA Import Refusal AEK-9170474-0/60003/1 — NAMAN PHARMA DRUGS
The FDA refused shipment AEK-9170474-0/60003/1 from NAMAN PHARMA DRUGS (India) on Jan 6, 2026. The refused product falls under Drugs and Biologics — CABERGOLINE (ANTI-PARKINSONIAN). Cited charge: 75
Refusal Details
- Date
- Jan 6, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62JCA12 CABERGOLINE (ANTI-PARKINSONIAN)
- Charges
- 75